Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New Parkinson's disease treatment option now available in Canada

Aug. 28, 1997

Morphine derivatives discovered by Nycomed

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Aug. 28, 1997

Immune Response's TCR vaccine evaluated in MS patients

Aug. 28, 1997

Calcium channel antagonist AJ-3941 for treatment of stroke

Aug. 27, 1997

S-15535 tested in preclinical models of anxiety and depression

Aug. 27, 1997

New treatment option for cancer pain

Aug. 27, 1997

Cognition enhancer found devoid of neurotoxicity in vitro

Aug. 26, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...